Neutropenic Diet (Diet B) for Myelodysplastic Syndrome

UF Health Cancer Center, Gainesville, FL
Myelodysplastic Syndrome+1 More ConditionsDiet - Other
All Sexes
What conditions do you have?

Study Summary

This trial will compare the safety of a diet with fresh fruits and vegetables to a neutropenic diet in patients with prolonged neutropenia.

Eligible Conditions
  • Myelodysplastic Syndrome
  • Leukemia

Treatment Effectiveness

Phase-Based Effectiveness

2 of 3
Phase 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 10 Secondary · Reporting Duration: 1 year

1 year
Admission frequency
Bone Transplantation
Incidence of infections in each diet group
Incidence of major infections
Incidence of mucositis
Overall survival (OS)
Patient-Generated Subjective Global Assessment (PG-SGA)
Progression free survival (PFS)
Quality of life (QoL)
Symptom incidence

Trial Safety

Phase-Based Safety

3 of 3
This is further along than 85% of similar trials

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2 Treatment Groups

Neutropenic Diet (Diet B)
1 of 2
Liberalized Hospital Diet (Diet A)
1 of 2

Active Control

470 Total Participants · 2 Treatment Groups

Primary Treatment: Neutropenic Diet (Diet B) · No Placebo Group · Phase 3

Neutropenic Diet (Diet B)
ActiveComparator Group · 1 Intervention: Diet · Intervention Types: Other
Liberalized Hospital Diet (Diet A)
ActiveComparator Group · 1 Intervention: Diet · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 1 year

Who is running the clinical trial?

University of FloridaLead Sponsor
1,274 Previous Clinical Trials
699,617 Total Patients Enrolled
Zeina A Al-Mansour, MDPrincipal InvestigatorUniversity of Florida

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Has the FDA cleared Diet B for cancer patients with low white blood cell counts?

"Since this is a Phase 3 trial, there is some data indicating that this diet is effective, and there have been multiple rounds of data supporting its safety, our team at Power has rated the safety of the Neutropenic Diet (Diet B) as a 3." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.